Independent Advisor Alliance Amgen Inc Transaction History

Independent Advisor Alliance

$2.71 Billion
Q3 2024

A detailed history of Independent Advisor Alliance transactions in Amgen Inc stock. As of the latest transaction made, Independent Advisor Alliance holds 27,999 shares of AMGN stock, worth $7.37 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

27,999

Previous 26,223 6.77%

Holding current value

$7.37 Million

Previous $8.19 Million 10.11%

% of portfolio

0.33%

Previous 0.28%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $549,458 - $599,186	1,776 Added 6.77%	27,999 $9.02 Million
Q2 2024 Aug 12, 2024	BUY	$262.75 - $319.31 $764,865 - $929,511	2,911 Added 12.49%	26,223 $8.19 Million
Q1 2024 May 08, 2024	BUY	$268.87 - $324.56 $77,703 - $93,797	289 Added 1.26%	23,312 $6.63 Million
Q4 2023 Feb 08, 2024	BUY	$255.7 - $288.46 $72,107 - $81,345	282 Added 1.24%	23,023 $6.63 Million
Q3 2023 Oct 24, 2023	BUY	$218.65 - $271.46 $211,434 - $262,501	967 Added 4.44%	22,741 $6.11 Million
Q2 2023 Jul 28, 2023	BUY	$214.27 - $253.37 $75,423 - $89,186	352 Added 1.64%	21,774 $4.83 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $30,255 - $36,876	-134 Reduced 0.62%	21,422 $5.18 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $63,441 - $80,609	-277 Reduced 1.27%	21,556 $5.66 Million
Q3 2022 Nov 04, 2022	BUY	$224.46 - $253.15 $186,077 - $209,861	829 Added 3.95%	21,833 $4.92 Million
Q2 2022 Aug 04, 2022	BUY	$230.71 - $256.74 $486,105 - $540,951	2,107 Added 11.15%	21,004 $5.11 Million
Q1 2022 May 06, 2022	BUY	$219.27 - $242.57 $382,187 - $422,799	1,743 Added 10.16%	18,897 $4.57 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $63,840 - $73,059	321 Added 1.91%	17,154 $3.86 Million
Q3 2021 Nov 01, 2021	BUY	$212.27 - $248.7 $159,414 - $186,773	751 Added 4.67%	16,833 $3.58 Million
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $636,271 - $705,897	2,724 Added 20.39%	16,082 $3.92 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $122,716 - $143,005	-553 Reduced 3.98%	13,358 $3.32 Million
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $72,054 - $85,804	333 Added 2.45%	13,911 $3.2 Million
Q3 2020 Nov 04, 2020	BUY	$234.65 - $260.95 $247,086 - $274,780	1,053 Added 8.41%	13,578 $3.45 Million
Q2 2020 Aug 06, 2020	SELL	$197.81 - $242.74 $68,442 - $83,988	-346 Reduced 2.69%	12,525 $2.95 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $386,531 - $512,645	-2,121 Reduced 14.15%	12,871 $2.61 Million
Q4 2019 Feb 07, 2020	BUY	$189.21 - $243.2 $126,013 - $161,971	666 Added 4.65%	14,992 $3.61 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $315,139 - $377,602	1,810 Added 14.46%	14,326 $2.81 Million
Q2 2019 Aug 12, 2019	BUY	$166.7 - $195.41 $510,435 - $598,345	3,062 Added 32.39%	12,516 $2.31 Million
Q1 2019 May 07, 2019	BUY	$180.87 - $203.88 $117,022 - $131,910	647 Added 7.35%	9,454 $1.8 Million
Q4 2018 Feb 12, 2019	SELL	$178.4 - $208.25 $21,408 - $24,990	-120 Reduced 1.34%	8,807 $1.71 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $68,927 - $77,707	372 Added 4.35%	8,927 $1.73 Million
Q2 2018 Aug 08, 2018	BUY	$166.05 - $186.51 $128,854 - $144,731	776 Added 9.98%	8,555 $1.5 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $42,526 - $49,698	-251 Reduced 3.13%	7,779 $1.29 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $187,694 - $209,712	1,112 Added 16.07%	8,030 $1.45 Million
Q3 2017 Nov 15, 2017	SELL	$167.29 - $191.0 $256,622 - $292,994	-1,534 Reduced 18.15%	6,918 $1.28 Million
Q2 2017 Aug 14, 2017	BUY	N/A	8,452	8,452 $1.46 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Independent Advisor Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Independent Advisor Alliance with notifications on news.

Account

Independent Advisor Alliance Amgen Inc Transaction History